The DPX Delivery Platform Enables Cancer Vaccines to be Clinically Viable

Time: 10:30 am
day: Day One

Details:

  • DPX is a unique lipid-in-oil, non-emulsion delivery formulation that educates a targeted and long-lasting immune response in regional lymph nodes
  • DPX can be formulated to deliver a variety of cargo (e.g. peptides, proteins, VLPs, TLRs, mRNA)
  • Proof of concept is clinically demonstrated in several hematologic and solid cancer indications

Speakers: